Research rticle Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan Humera Bukhari, 1 Aneeqa Ahmad, 2 Amna Noorin, 3 Aimal Khan, 4 Mehwish Mushtaq , 5 Aamir Naeem, 6 Muhammad Rashid Iqbal, 7 Faiza Naureen, 8 Yasar Shah, 8 Ahad Qayyum, 9 Syed Munib, 10 Amer Azhar, 11 Farman Ullah, 11 and Faris Farooq Saeed Khan 12 1 Nephrology Ward, Jinnah Teaching Hospital, Khyber Pakhtunkhwa, Peshawar, Pakistan 2 District Headquarters DHQ Hospital, Faisalabad, Punjab, Pakistan 3 Peshawar Institute of Cardiology •M.T. I, Khyber Pakhtunkhwa, Peshawar, Pakistan 4 Northwest General Hospital and Research Center, Khyber Pakhtunkhwa, Peshawar, Pakistan 5 Department of Pharmacy, University of Peshawar, Khyber Pakhtunkhwa, Peshawar, Pakistan 6 Consultant Physician in Endocrinology, Madinat Zayed Hospital SEH bu Dhabi Health Services, bu•Dhabi, UE 7 Consultant Physician in Medicine, University Hospital Birmingham, UK 8 Department of Pharmacy, bdul Wali Khan University Mardan, Khyber Pakhtunkhwa, Pakistan 9 Nephrology Ward, Bahria International Hospital, Lahore, Pakistan 10 Nephrology Ward, Institute of Kidney Disease Hayatabad Peshawar, Khyber Pakhtunkhwa, Peshawar, Pakistan 11 Nephrology Ward, Khyber Teaching Hospital M. T. I., Khyber Pakhtunkhwa, Peshawar, Pakistan 12 Department of Community Health Sciences, ga Khan University, Karachi, Pakistan CorrespondenceshouldbeaddressedtoMehwishMushtaq;mahmushtaq@gmail.com Received 7 October 2022; Revised 12 December 2022; Accepted 9 January 2023; Published 13 February 2023 AcademicEditor:B.D.Parameshachari Copyright © 2023 Humera Bukhari et al. Tis is an open access article distributed under the Creative Commons Attribution License,whichpermitsunrestricteduse,distribution,andreproductioninanymedium,providedtheoriginalworkisproperly cited. End•stage renal disease (ESRD) patients are mostly managed with maintenance hemodialysis (MHD). ESRD patients on MHD alsopresentwithmanycomplications,suchasanemia,hyperparathyroidism,andhepatitisprevalence.Tisstudydepictsthereal• world scenario of anemia among MHD and end•stage renal disease patients in the Pakistani population. A retrospective, multicentric,andreal•worlddataanalyticalstudywasconductedat4dialysiscentersinPakistan.Testudyhadasamplesizeof n =342 patients on maintenance hemodialysis. Te data were gathered from the medical records of patients. Data analysis was performedusingSTATAVersion16.Statisticalsignifcancewasgaugedata0.05levelofsignifcance.Accordingtoourresults,the meanageofthepatientswas45(±15)years.Mostofthepatientsweremale(n =234,68.4%),whereas58.1%ofthepatientswere maintainedontwice•weeklyhemodialysis.Temostcommonlyreportedcomorbiditieswerehypertensionanddiabetesmellitus. Tefrequencyofdialysis(P < 0.01)andcomorbidities(P =0.009)hadasignifcantassociationwithanemiainMHDpatients.Te majority of the patients had hyperparathyroidism (52%) with anemia. Upon performing binary logistic regression, multivariate analysisdisplayedasimilaroddsvalueforhavinganemiainpatientswitheveryadditionalmonthinthedurationofhemodialysis (OR1.01, P =0.001),theoddsofanemicpatientshavingapositiveantihepatitis•Cantibody(OR2.22, P =0.013),andtheoddsof havinganemiainpatientsintheagecategorybelow45years(OR1.93, P =0.013).Inconclusion,thestudyresultsdepictthatevery additional month in the duration of hemodialysis, age (<45 years), and positive anti•HCV antibody status, these variables were more likely to have anemia in our study MHD patients. While in our fnal multivariate model, no statistically signifcant as• sociation was observed between hyperparathyroidism and anemia. Hindawi International Journal of Clinical Practice Volume 2023, Article ID 7418857, 12 pages https://doi.org/10.1155/2023/7418857